Our Story

Our Location

Strategically located for access to extensive volunteer population and patient network

Headquarters in Northern Germany

  • Hamburg population approx. 2 million
  • Bremen population approx. 0.5 million
  • Hannover population approx. 0.5 million

On the Campus of University Medical Center Hamburg-Eppendorf (UKE)

  • 41 clinical departments
  • 38 research institutes
  • 90,000 admissions per year
  • 400,000 outpatient appointments per year

About CTC North

Skilled, experienced team of clinical research professionals

Trusted industry partner including collaboration with the University Medical Center Hamburg

Fully GCP compliant and externally audited

Reliable and fast recruitment

Experienced in a range of therapeutic areas​

Therapeutic Areas

Broad experience across a wide spectrum of therapeutic areas with fully integrated capabilities to conduct Phase I-IV clinical trials from trial design to conduct

Cardiology

Oncology

Stem Cell Transplantation

COVID

Neurology

Vaccine Studies

Dermatology

Endocrinology

Immunology

Pediatrics

Psychiatry

Surgical Disciplines

Therapeutic Areas

Broad experience across a wide spectrum of therapeutic areas with fully integrated capabilities to conduct Phase I-IV clinical trials from trial design to conduct

Cardiology

Stem Cell Transplantation

Vaccine Studies

Immunology

Psychiatry

Dermatology

Oncology

Endocrinology

Pediatrics

Neurology

Surgical Disciplines

COVID

Proven excellence in conducting early & late phase clinical research

0 +
YEARS OF EXPERIENCE
0 +
STUDIES PERFORMED TO DATE
0 +
SUBJECTS DOSED IN-HOUSE
0 +
ACTIVE STUDIES

Proven excellence in conducting early & late phase clinical research

0 +
YEARS OF EXPERIENCE
0 +
STUDIES PERFORMED TO DATE
0 +
SUBJECTS DOSED IN-HOUSE
0 +
ACTIVE STUDIES

Our Phase I Unit

  • 27 beds
  • 10 beds with cardiovascular monitoring 
  • Electronic medical record system (15 mobile units)
  • 2 separate clinical stations for ambulatory examinations and subject confinement
  • IMP dosing preparation and reconstitution 
  • Unblinded and blinded services 
  • IMP and sample storage (room temperature to -140°C)
  • On-site PBMC processing 

Study Recruitment

EARLY & LATE PHASE TRIAL MANAGEMENT SERVICES

Consulting & Feasibility

Site Management

Pharmacovigilance

Regulatory

Project Management

Clinical Monitoring

Data Management

Medical Writing

Quality Assurance, Management & Audits

EARLY & LATE PHASE TRIAL MANAGEMENT SERVICES

Consulting & Feasibility

Site Management

Pharmacovigilance

Regulatory

Project Management

Quality Assurance, Management & Audits

Clinical Monitoring

Data Management

Medical Writing

THE FACTS

0 +
Projects completed
0
Audits performed
0
In-House Physicians
0
Employees in Germany
0 %
Employees with advanced degrees
0 +
Countries covered
0
Employees globally
0
Employees with PhDs
0 %
Repeat Business Rate

THE FACTS

0 +
Projects completed
0
Audits performed
0
In-House Physicians
0
Employees in Germany
0 %
Employees with advanced degrees
0 +
Countries covered
0
Employees globally
0
Employees with PhDs
0 %
Repeat Business Rate

Recent Success Stories (NCT04335136)

Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (APN01-COVID-19) (NCT04335136)

We are growing…stay tuned

Barbara Clajus
Director Clinical Monitoring
Joanna Korbiel
Director Account & Project Management
Dr. Courtney Metz
Director Regulatory & Safety Management